- Conditions
- Atrial Fibrillation (AF)
- Interventions
- Pulmonary Vein Isolation, vMap® + Pulmonary Vein Isolation
- Procedure · Device
- Lead sponsor
- Vektor Medical
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 423 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 12
- States / cities
- Jonesboro, Arkansas • Clearwater, Florida • Jacksonville, Florida + 9 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 256
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
- Interventions
- Ablation
- Procedure
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 18 Years to 80 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- Ridgewood, New Jersey
- Conditions
- Atrial Fibrillation (AF)
- Interventions
- Pulmonary Vein Isolation (PVI) without Left Atrial Posterior Wall Isolation (PWI), Pulmonary Vein Isolation (PVI) with Left Atrial Posterior Wall Isolation (PWI)
- Procedure
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 630 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Atrial Fibrillation
- Interventions
- Not listed
- Lead sponsor
- Itamar-Medical, Israel
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 3
- States / cities
- New York, New York • Austin, Texas
- Conditions
- Atrial Fibrillation (AF)
- Interventions
- Abelacimab, Placebo
- Biological · Drug
- Lead sponsor
- Anthos Therapeutics, Inc.
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 1,900 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 150
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Gilbert, Arizona + 129 more
- Conditions
- Atrial Fibrillation (AF)
- Interventions
- Not listed
- Lead sponsor
- Larisa Tereshchenko, MD, PhD
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 336 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Atrial Fibrillation
- Interventions
- CTI ablation Timing
- Procedure
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 132 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2010
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Atrial Fibrillation
- Interventions
- AFSW Guided DOAC, Continuous DOAC therapy
- Device · Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 22 Years to 85 Years
- Enrollment
- 5,350 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2029
- U.S. locations
- 93
- States / cities
- Phoenix, Arizona • Los Angeles, California • Sacramento, California + 68 more
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Meditation, AF Education, Phone Calls
- Behavioral · Other
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2025
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Atrial Arrhythmia, Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
- Interventions
- Pulsed Field Ablation
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 392 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 26
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 22 more
- Conditions
- Atrial Fibrillation
- Interventions
- Catheter Ablation
- Device
- Lead sponsor
- Heart Rhythm Clinical and Research Solutions, LLC
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 392 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 4
- States / cities
- Birmingham, Alabama • Annapolis, Maryland • Boston, Massachusetts + 1 more
- Conditions
- Atrial Fibrillation, Atrial Flutter
- Interventions
- Zio®XT Monitor
- Other
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Eligibility
- 70 Years and older
- Enrollment
- 11,931 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 176
- States / cities
- Birmingham, Alabama • Guntersville, Alabama • Montgomery, Alabama + 141 more
- Conditions
- Atrial Fibrillation, Left Atrial Appendage Thrombosis, CVA
- Interventions
- LAmbre PlusTM Left Atrial Appendage Closure System, Market approved oral anticoagulation (OAC), such as warfarin (Coumadin), dabigatran (Pradaxa), rivaroxaban (Xarelto), apixiban (Eliquis), edoxaban (Savaysa), or betrixaban (Bevyxxa)
- Device · Drug
- Lead sponsor
- Brian O'Neill MD
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Typical Atrial Flutter, Risk Factors With Future Development of Atrial Flutter
- Interventions
- CTI ablation alone, CTI ablation and Pulmonary vein isolation (PVI)
- Procedure
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Atrial Fibrillation (AF), Atrial Fibrillation (Paroxysmal)
- Interventions
- Alcohol Consumption Randomized Instructions
- Behavioral
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 2
- States / cities
- San Francisco, California
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Persistent AF ablation assisted with the STAR Apollo Mapping System
- Other
- Lead sponsor
- Kansas City Heart Rhythm Research Foundation
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 4
- States / cities
- Jonesboro, Arkansas • Sarasota, Florida • Overland Park, Kansas
- Conditions
- Atrial Fibrillation, Cerebrothromboembolus, Neurocognitive Function
- Interventions
- Atrial Fibrillation Ablation
- Procedure
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Atrial Fibrillation (AF), Atrial Fibrillation Patients Treated With the FARAPULSE™ PFA System, Atrial Fibrillation (Paroxysmal), Pulmonary Vein Isolation
- Interventions
- AF Recurrence RIsk Assessment post pulmonary vein isolation
- Device
- Lead sponsor
- CathVision ApS
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Paramus, New Jersey
- Conditions
- Atrial Fibrillation
- Interventions
- Catheter Ablation
- Device
- Lead sponsor
- Volta Medical
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 96 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Jonesboro, Arkansas • Jacksonville, Florida + 11 more
- Conditions
- Atrial Fibrillation
- Interventions
- Reveal XT implantable loop recorder
- Device
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Atrial Fibrillation
- Interventions
- TTM and Holter monitor
- Other
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 68 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2016
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
- Interventions
- Catheter ablation
- Device
- Lead sponsor
- Heart Rhythm Clinical and Research Solutions, LLC
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2027
- U.S. locations
- 64
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 57 more
- Conditions
- Atrial Fibrillation
- Interventions
- Parasym
- Device
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 81 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Persistent Atrial Fibrillation
- Interventions
- Sphere-9™ Catheter and Affera™ Ablation System
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Sarasota, Florida • Atlanta, Georgia + 11 more